Crystal's Coder Hub🧬 ICD-10 CM C77.0 — Secondary and Unspecified Malignant Neoplasm of Lymph Nodes of Head, Face and Neck
Billable Code Confirmed
ICD-10 CM C77.0 is a valid, billable 5-character ICD-10-CM code effective for FY2026. It is classified under Chapter 2 (Neoplasms) in the C76-C80 block covering malignant neoplasms of ill-defined, secondary and unspecified sites. This code captures secondary (metastatic) malignant disease that has spread to the lymph nodes of the head, face, or neck — including the ∫— from a primary malignancy elsewhere. No additional characters are required; C77.0 is the terminal billable code at this level of the hierarchy.
Non-Billable Parent Codes
- C77 (Secondary and unspecified malignant neoplasm of lymph nodes) — Non-billable header category; captures all lymph node metastasis sites collectively but lacks the regional specificity required for submission. A fifth character identifying the lymph node region (head/neck, intrathoracic, intra-abdominal, etc.) is always required.
- C76-C80 block header — Non-billable; this is a range descriptor for ill-defined, secondary, and unspecified malignant neoplasms in the Tabular, not an assignable code.
Clinical Context
ICD-10 CM C77.0 represents metastatic spread of a primary cancer to the lymph nodes of the head, face, and neck — it is never used for primary lymph node malignancies (those are classified under lymphoma/leukemia codes C81-C86, C88, C96). The most common primary tumors driving C77.0 in clinical practice include head and neck squamous cell carcinoma (oral cavity, oropharynx, larynx, hypopharynx), thyroid carcinoma, melanoma of the head and neck, and less frequently, cancers of the lung, breast, or other sites that drain to supraclavicular nodes. Per ICD-10-CM Official Guideline I.C.2, when a patient has both a primary malignancy and metastatic lymph node disease, both the primary code and C77.0 should be assigned; sequencing depends on the clinical circumstances of the encounter.
Code Classification
ICD-10 CM C77.0 is a secondary malignant neoplasm (metastatic/diagnosis) code — it represents active, current metastatic disease in lymph nodes of the head, face, and neck. It is never a primary lymph node malignancy code, not a lymphoma code, not a history code, and not a procedure code. It is categorically distinct from primary lymph node cancers (e.g., Hodgkin lymphoma C81.xx, diffuse large B-cell lymphoma C83.3x) and must never be used to represent those conditions.
🔍 Code Description
ICD-10 CM C77.0 classifies secondary (metastatic) malignant neoplasms that have spread to the lymph nodes of the head, face, and neck, including the supraclavicular lymph nodes. According to ICD-10-CM inclusion terms, this code specifically encompasses supraclavicular lymph node metastasis — clinically significant because supraclavicular nodal involvement often signals spread from a thoracic or abdominal primary (e.g., Virchow’s node from gastric or lung cancer) and carries important staging and prognostic implications. The cervical lymph node chains — including the submandibular (Level I), upper/mid/lower jugular (Levels II-IV), posterior triangle (Level V), and supraclavicular (Level IV/VB) nodes — are the most commonly involved in head and neck primary cancers, and the anatomical level of nodal disease is a critical driver of TNM staging and surgical planning. C77.0 encompasses all of these regional node groups when documented as site of metastatic spread.
In the inpatient setting, C77.0 is almost always assigned as an additional (secondary) code alongside the primary malignancy code that drove the admission. Per ICD-10-CM Official Guideline I.C.2.b, when a patient’s primary malignancy has metastasized, all documented sites of metastasis should be captured. The presence of C77.0 enriches the clinical picture, supports staging documentation, reflects clinical complexity for DRG weight purposes, and is a key data point for cancer registry submission. In head and neck cancer encounters, C77.0 most commonly pairs with primaries such as C32.0 (glottic larynx), C10.9 (oropharynx), C06.9 (mouth), C73 (thyroid), or C43.xx (melanoma of head and neck region).
🌳 Code Tree / Hierarchy
C77 Secondary and unspecified malignant neoplasm of lymph nodes ❌ Non-billable
│
├── C77.0 Secondary and unspecified malignant neoplasm of
│ lymph nodes of head, face and neck ◀ THIS CODE ✅ Billable
│ (Includes: supraclavicular lymph nodes)
│
├── C77.1 Secondary and unspecified malignant neoplasm of
│ intrathoracic lymph nodes ✅ Billable
│
├── C77.2 Secondary and unspecified malignant neoplasm of
│ intra-abdominal lymph nodes ✅ Billable
│
├── C77.3 Secondary and unspecified malignant neoplasm of
│ axilla and upper limb lymph nodes ✅ Billable
│
├── C77.4 Secondary and unspecified malignant neoplasm of
│ inguinal and lower limb lymph nodes ✅ Billable
│
├── C77.5 Secondary and unspecified malignant neoplasm of
│ intrapelvic lymph nodes ✅ Billable
│
├── C77.8 Secondary and unspecified malignant neoplasm of
│ lymph nodes of multiple regions ✅ Billable
│
└── C77.9 Secondary and unspecified malignant neoplasm of
lymph node, unspecified ✅ Billable
Regional Specificity Drives Code Selection
The C77 category is subdivided entirely by anatomical lymph node region. C77.0 applies when the head, face, or neck nodes (including supraclavicular) are the documented site of metastasis. If nodal disease spans multiple regions (e.g., cervical AND axillary), use C77.8 (multiple regions) rather than stacking individual C77 codes. If the specific lymph node region is not documented, C77.9 (unspecified) is appropriate — but always query the provider for specificity first, as region-specific coding supports staging, registry accuracy, and surgical planning documentation.
C77.0 vs. Primary Lymphoma — Never Interchange
The single most high-risk error with C77.0 is confusing metastatic carcinoma to lymph nodes with a primary lymph node malignancy (lymphoma). C77.0 is for carcinoma (or other non-lymphomatous cancers) that have spread to lymph nodes — the primary tumor originated elsewhere. Lymphomas (Hodgkin, non-Hodgkin) arise in the lymph nodes as their primary site and are coded under C81-C86, which carry an Excludes 1 relationship with C77. If documentation describes “lymph node malignancy” without clarity, query the provider for primary vs. secondary before assigning either.
✅ Includes
- Secondary malignant neoplasm of supraclavicular lymph nodes: The supraclavicular nodes are an inclusion term for C77.0; Virchow’s node (left supraclavicular) involvement from a gastric or thoracic primary is captured here, even though the primary site may be distant from the head/neck.
- Cervical lymph node metastasis (all levels I-V): Metastatic carcinoma to any of the cervical lymph node levels from a head and neck primary is captured under C77.0, making this code essential in virtually all advanced head and neck cancer inpatient encounters.
- Submandibular and submental node metastasis: Level I nodal disease from oral cavity, lip, or floor-of-mouth primaries maps to C77.0, reflecting the regional drainage pattern of anterior oral structures.
- Posterior triangle (Level V) nodal metastasis: Level V cervical nodes are included; disease in this region is associated with nasopharyngeal, thyroid, and skin primaries and has specific surgical and radiation planning implications.
- Facial and parotid region lymph node metastasis: Metastatic disease to periparotid or facial lymph nodes — commonly from cutaneous melanoma, squamous cell carcinoma of the face, or parotid region primaries — falls under C77.0.
❌ Excludes
Excludes 1
These codes represent mutually exclusive conditions — do not assign with C77.0:
- C81-C86, C88, C96.x — Malignant neoplasm of lymph nodes specified as primary: These codes cover Hodgkin lymphoma, non-Hodgkin lymphomas, Burkitt lymphoma, mycosis fungoides, and other primary lymph node malignancies. When the lymph node disease IS the primary cancer (lymphoma), these codes are used — C77.0 is explicitly excluded. The two code types (primary lymphoma vs. secondary carcinoma to lymph nodes) can never be assigned for the same lymph node when there is a single clinical process. Provider documentation must clearly identify whether the lymph node malignancy is primary (lymphoma/leukemia) or secondary (metastasis from a solid tumor elsewhere) before code assignment.
- C7B.01— Secondary carcinoid tumors of distant lymph nodes: Neuroendocrine/carcinoid tumor metastasis to lymph nodes is classified separately under the C7B secondary neuroendocrine tumor block, not under C77. When the primary tumor is a carcinoid (neuroendocrine) tumor, use C7B.01 rather than C77.0 for distant lymph node metastasis.
- C7B.04 — Mesentery metastasis of carcinoid tumor: Separately classified carcinoid metastasis pattern; not applicable to C77.0.
Lymphoma vs. Metastatic Carcinoma to Nodes — Top Compliance Risk
Assigning C77.0 when the correct code is a lymphoma code (C81-C86) is a critical coding error that misclassifies disease type, distorts cancer registry data, and produces incorrect MS-DRG assignment and HCC capture. The Excludes 1 relationship makes simultaneous use of C77.0 and a C81-C86 code for the same lymph node a hard rule violation. When provider documentation is ambiguous — for example, “lymph node malignancy” without specifying primary vs. secondary — a CDI query is mandatory before code assignment. Biopsy pathology report terminology (e.g., “metastatic SCC” vs. “large cell lymphoma”) can guide the query, but provider clinical documentation governs the final code selection.
Excludes 2
These conditions are not included in C77.0 but may be coded additionally when clinically documented:
- C77.8 — Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions: When lymph node metastasis is documented in the head/neck region and in at least one other lymph node region (e.g., cervical nodes AND mediastinal nodes), use C77.8 rather than assigning both C77.0 and C77.1 separately. C77.8 captures multi-region nodal disease in a single code and is the correct code when the spread is explicitly documented across multiple nodal regions.
📋 Clinical Overview
Secondary Lymph Node Malignancy vs. Primary Lymph Node Malignancy
The fundamental clinical and coding distinction for C77.0 is whether the lymph node malignancy is a metastasis from a primary tumor elsewhere (use C77.0) or a primary lymph node cancer (use C81-C86). This distinction drives the entire code selection, DRG assignment, HCC mapping, and cancer registry classification. Metastatic carcinoma in cervical lymph nodes from a known head and neck primary is the most common C77.0 scenario in inpatient ENT oncology coding.
| Feature | [[C77.0]] Secondary LN Metastasis | C81-C86 Primary Lymphoma | Notes for Coders |
|---|---|---|---|
| Origin of malignancy | Primary tumor at another anatomical site (e.g., larynx, thyroid, oral cavity) | Primary malignancy arises in the lymph node/lymphatic tissue itself | Requires explicit provider documentation of primary vs. secondary |
| Histology | Carcinoma (SCC, adenocarcinoma, etc.) matching the primary site | Lymphoma cell types (Reed-Sternberg cells, B-cell, T-cell lymphoma) | Biopsy pathology will distinguish — guide CDI query |
| Always paired with primary code? | Yes — ICD-10-CM Guideline I.C.2 requires primary code alongside C77.0 | No — lymphoma codes are standalone principal diagnoses | Critical sequencing difference |
| HCC mapping | HCC 12 (Lung and Other Severe Cancers) — V28 | HCC 10 (Lymphoma and Other Cancers) — V28 | Different HCC categories; confirms why lymphoma vs. met distinction matters for RAF |
| DRG when principal | Driven by primary malignancy code sequence | MDC 17 (Myeloproliferative Diseases) typically | DRG pathway is completely different |
| Excludes 1 relationship | Cannot be coded with C81-C86 for same node | Cannot be coded with C77.0 for same node | Hard rule — query provider if ambiguous |
CDI Trigger — Primary vs. Secondary Lymph Node Malignancy
Any encounter with a documented lymph node malignancy where the provider has not explicitly stated whether it is a primary lymphoma or metastatic carcinoma represents a mandatory CDI query opportunity. Pathology report language — “metastatic squamous cell carcinoma in lymph node” vs. “diffuse large B-cell lymphoma” — provides strong clinical guidance for the query, but the treating provider must make the final clinical determination that is documented in the medical record. Coding from the pathology report alone without provider attestation is non-compliant.
Manifestations & Symptom Burden
- Palpable Cervical Mass: The most common presenting sign of head and neck nodal metastasis; when documented as the reason for admission or workup, code the known or suspected underlying primary alongside C77.0.
- Neck Pain / Referred Otalgia: Advanced cervical nodal disease may produce pain from nerve involvement; separately codeable when documented (G54.2 — cervical root disorders, or R68.89 — other general symptoms).
- Dysphagia: Bulky cervical adenopathy from nodal metastasis may compress the pharynx or esophagus, contributing to documented dysphagia (R13.10-R13.19); separately codeable and may function as a CC.
- Trismus: Advanced nodal disease or post-treatment fibrosis from neck dissection/radiation can cause trismus (M26.64); a separately codeable, clinically significant comorbidity in this population.
- Superior Vena Cava Syndrome (in supraclavicular/mediastinal extension): Massive supraclavicular nodal disease with mediastinal extension may contribute to SVC syndrome (J98.19 or I87.1); a high-acuity comorbidity that may function as an MCC depending on principal diagnosis.
Manifestation and Comorbidity Coding
ICD-10 CM C77.0 is never coded as a manifestation code — it is a secondary malignancy code that stands as an additional diagnosis alongside the primary malignancy. When documenting secondary codes in head and neck cancer encounters, be thorough: dysphagia, malnutrition (E43/E44.x — frequently MCC-level), tracheostomy status (Z93.0), and post-radiation sequelae (e.g., M35.04 — radiation fibrosis, or T66.XXXA — radiation effects) are common, often CC/MCC-level, and frequently undercoded in oncology encounters.
💰 HCC Risk Adjustment
| HCC Model | HCC Category | RAF Impact | Notes |
|---|---|---|---|
| CMS-HCC V28 (PY2026) | HCC 12 — Lung and Other Severe Cancers | High RAF contribution | Fully implemented PY2026; direct ICD-10-CM mapping |
| CMS-HCC V24 (legacy, fully phased out 2026) | HCC 12 — Lung and Other Severe Cancers | High RAF contribution | V24 fully replaced by V28 for PY2026 |
| CDPS / Medicaid | High-cost active malignancy tier | Varies by state model | Captured as active metastatic malignancy |
ICD-10 CM C77.0 maps to HCC 12 (Lung and Other Severe Cancers) under CMS-HCC V28, the fully operational model for payment year 2026. The presence of lymph node metastasis signals active, metastatic malignancy — a designation that carries a substantial RAF weight due to the high predicted cost burden of metastatic cancer care (systemic therapy, surgery, radiation, supportive care). Because C77.0 is a secondary malignancy code, it should always be captured alongside the primary malignancy code (which may also map to HCC 12 or another HCC category depending on the primary site) — both should be documented and coded to reflect the full scope of metastatic disease. In Medicare Advantage and ACO REACH contracts, annual documentation of active nodal metastasis is essential; if the patient is receiving ongoing treatment for or monitoring of nodal disease, C77.0 must be coded every relevant encounter year to prevent RAF score drop. History codes (Z85.xx) should only replace C77.0 when the metastatic disease is fully resolved with no current treatment or monitoring.
🏥 MS-DRG Assignment
ICD-10 CM C77.0 does not independently drive MS-DRG assignment — the DRG is governed by the principal diagnosis. However, C77.0 frequently contributes as an additional code that affects CC/MCC status and DRG tier.
| Clinical Scenario | Principal Dx | C77.0 Role | Likely MDC | Example DRG |
|---|---|---|---|---|
| Glottic cancer with cervical nodal mets, medical admission | C32.0 | Additional — CC potential | MDC 3 | DRG 146 (w/MCC), 147 (w/CC), 148 (w/o CC/MCC) |
| Glottic cancer with laryngectomy and neck dissection | C32.0 | Additional — CC potential | MDC 3 | DRG 011/012/013 (surgical — O.R. procedure drives) |
| Thyroid cancer with cervical mets, thyroidectomy | C73 | Additional | MDC 10 | Varies by endocrine surgical DRG |
| Unknown primary cancer with cervical LN metastasis | C80.1 | Additional or co-equal Dx | MDC varies | DRG 055-057 (misc neoplasm) depending on workup |
| Lung cancer with supraclavicular nodal mets (Virchow’s node) | C34.xx | Additional | MDC 4 | Respiratory malignancy DRGs 582-585 |
ICD-10 CM C77.0 may qualify as a CC-level comorbidity depending on the principal diagnosis and the CC/MCC exclusion table — active metastatic lymph node disease often meets the threshold. Coders must verify CC/MCC exclusion edits for each specific principal-secondary code combination. When neck dissection is performed during the inpatient stay, the corresponding ICD-10-PCS resection/excision of lymph nodes procedure code drives the encounter into the surgical DRG grouping, typically yielding a substantially higher relative weight. Documentation of the extent of neck dissection (selective, modified radical, or radical) is needed for accurate PCS code selection and supports medical necessity.
🔗 Related ICD-10-CM Codes
C77 Sibling Codes — Lymph Node Metastasis by Region:
- C77.1 — Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes
- C77.2 — Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
- C77.3 — Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes
- C77.8 — Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions (use when multi-region nodal disease is documented)
- C77.9 — Secondary and unspecified malignant neoplasm of lymph node, unspecified (avoid — query for region specificity)
Common Head and Neck Primary Malignancy Codes Paired with C77.0:
- C32.0 — Malignant neoplasm of glottis (most commonly paired in ENT inpatient coding)
- C32.1 — Malignant neoplasm of supraglottis
- C73 — Malignant neoplasm of thyroid gland
- C10.9 — Malignant neoplasm of oropharynx, unspecified
- C06.9 — Malignant neoplasm of mouth, unspecified
- C43.9 — Malignant melanoma of skin, unspecified (when head/neck melanoma with nodal mets)
Mutually Exclusive Primary Lymph Node Malignancies (NEVER combine with C77.0):
- C81.xx — Hodgkin lymphoma (non-billable at 4-char level; requires 5th character)
- C83.3x — Diffuse large B-cell lymphoma
- C85.xx — Other and unspecified types of non-Hodgkin lymphoma
🛠️ Commonly Associated CPT Codes
-
38720 — Cervical lymphadenectomy (complete): Complete cervical lymph node dissection (radical neck dissection) for head and neck cancer with confirmed or suspected nodal metastasis is one of the primary surgical procedures associated with C77.0. On the inpatient facility side, the corresponding ICD-10-PCS resection of lymphatic structures code is the O.R. procedure that may influence DRG assignment. Documentation must specify extent (radical, modified radical, selective) for accurate PCS coding.
-
38724 — Cervical lymphadenectomy (modified radical neck dissection): Modified radical neck dissection, which spares one or more non-lymphatic structures (internal jugular vein, sternocleidomastoid, or spinal accessory nerve), is the most common neck dissection variant performed for N+ head and neck cancer. C77.0 supports medical necessity for this procedure alongside the primary malignancy code.
-
38500 — Biopsy or excision of lymph node(s); open, superficial: Open biopsy of a cervical lymph node may be performed to establish or confirm the diagnosis of nodal metastasis (confirming C77.0 vs. primary lymphoma). This code is used when the biopsy is the defining procedure of the encounter.
-
38792 — Injection procedure for identification of sentinel node: Sentinel lymph node biopsy for head and neck melanoma or oral cavity SCC uses this injection code paired with 38900 (intraoperative identification). C77.0 would be coded post-sentinel biopsy only when metastatic disease is confirmed; prior to confirmation, code the primary malignancy and a rule-out scenario per encounter-specific guidelines.
-
77301 / 77385 / 77386 — IMRT planning and delivery: Radiation therapy targeting the cervical lymph node chain (nodal radiation) alongside the primary tumor bed is standard of care for most N+ head and neck cancers. C77.0 as an additional diagnosis on radiation treatment encounters supports medical necessity for extended nodal field radiation planning. IMRT planning (77301) and delivery (77385/77386) codes are predominantly professional/outpatient but appear frequently in the diagnosis coding context alongside C77.0.
-
96413 / 96415 — Chemotherapy administration, IV infusion: Concurrent systemic chemotherapy for locoregionally advanced (N+) head and neck cancer is a standard treatment; C77.0 alongside the primary site code documents the metastatic disease burden justifying systemic therapy and supports medical necessity.
NCCI Bundling Considerations
For neck dissection procedures, NCCI edits bundle exploratory cervical lymphadenectomy with definitive radical or modified radical neck dissection when performed at the same operative session — the definitive procedure should be coded. Sentinel lymph node injection (38792) may bundle with sentinel node excision codes depending on payer policy; separate billing requires documentation that the injection and excision are distinct, separately reported components. Radiation therapy planning (77301) bundles with simulation codes under NCCI; coders and billers should verify which planning components remain separately billable under applicable payer contracts.
🔬 ICD-10-PCS Crosswalk
C77.0 is an ICD-10-CM diagnosis code. The following ICD-10-PCS codes are commonly assigned in inpatient encounters where C77.0 is documented:
-
07T20ZZ — Resection of Right Neck Lymphatic, Open Approach: Represents complete resection of right cervical lymph nodes (right radical/modified radical neck dissection). This is the PCS Root Operation for complete removal of a lymph node chain; use Resection when all nodes in a defined region are removed, as opposed to Excision for partial removal. Selecting the correct laterality character (right vs. left) and the correct Root Operation (Resection vs. Excision) are the two most common PCS accuracy issues in neck dissection coding.
-
07T30ZZ — Resection of Left Neck Lymphatic, Open Approach: Left-sided cervical lymph node resection (left neck dissection). Bilateral neck dissection at the same operative session requires coding both 07T20ZZ and 07T30ZZ per ICD-10-PCS multiple procedure rules.
-
07B20ZX — Excision of Right Neck Lymphatic, Open Approach, Diagnostic: Represents open biopsy (excision for diagnostic purposes) of right cervical lymph nodes. The qualifier X (diagnostic) distinguishes biopsy from therapeutic excision; this is the PCS code for open cervical node biopsy performed to confirm or establish the diagnosis coded as C77.0.
-
07B30ZX — Excision of Left Neck Lymphatic, Open Approach, Diagnostic: Left-sided open cervical lymph node biopsy for diagnostic purposes. As with the right-sided code, the diagnostic qualifier (X) is required to distinguish biopsy from therapeutic resection.
💊 Coding Scenarios and Examples
Scenario 1 — Glottic Cancer with Confirmed Cervical Nodal Metastasis, Laryngectomy and Neck Dissection
A 67-year-old male with previously diagnosed T3N1M0 squamous cell carcinoma of the glottis was admitted for total laryngectomy with left modified radical neck dissection. The operative report confirmed metastatic SCC in three Level II-III left cervical lymph nodes. The provider’s discharge summary documented “malignant neoplasm of the glottis with left cervical lymph node metastasis, T3N1M0; total laryngectomy and left modified radical neck dissection performed.”
Correct Coding:
- Principal Dx: C32.0 — Malignant neoplasm of glottis
- Additional: C77.0 — Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
- ICD-10-PCS: 0CT30ZZ — Resection of Larynx, Open Approach
- ICD-10-PCS: 07T30ZZ — Resection of Left Neck Lymphatic, Open Approach
Sequencing: C32.0 is principal (condition chiefly responsible for admission); C77.0 is additional, capturing the N1 nodal disease. The laryngectomy and neck dissection PCS codes are O.R. procedures that drive the DRG to the surgical grouping (DRG 011/012/013).
CDI Note: Confirm the provider documents both the primary site (glottis) and the nodal metastasis explicitly in the discharge summary or operative note — do not rely solely on the pathology report. Staging (T3N1M0) in the documentation is an excellent CDI quality indicator but does not replace explicit anatomical diagnosis documentation.
Scenario 2 — Cervical Lymph Node Mass, Unknown Primary
A 59-year-old male presented with a six-week history of a painless left neck mass. Core needle biopsy confirmed metastatic squamous cell carcinoma. After extensive workup including PET-CT, panendoscopy, and HPV testing, no primary tumor was identified. The attending documented “metastatic squamous cell carcinoma to left cervical lymph nodes, unknown primary.”
Correct Coding:
- Principal Dx: C77.0 — Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
- Additional: C80.1 — Malignant (primary) neoplasm, unspecified (unknown primary)
Sequencing: In this scenario, C77.0 may be sequenced as principal because the nodal metastasis is the confirmed diagnosis driving admission and workup, while C80.1 reflects the unidentified primary. Per ICD-10-CM Guideline I.C.2.d, when the primary malignancy is unknown, C80.1 is assigned for the unknown primary alongside the known secondary site code.
CDI Note: Query the provider if documentation says “possible primary in oropharynx” or “likely HPV-associated” — if a suspected primary site is identified, a more specific primary code may be appropriate even if not confirmed, depending on guideline applicability. “Unknown primary” is a valid and compliant clinical diagnosis when documentation supports it.
Scenario 3 — Thyroid Cancer with Bilateral Cervical Lymph Node Metastasis, Total Thyroidectomy
A 44-year-old female was admitted for total thyroidectomy with bilateral central and lateral neck dissection for papillary thyroid carcinoma with bilateral cervical lymph node metastases documented on pre-operative ultrasound and confirmed on intraoperative frozen section.
Correct Coding:
- Principal Dx: C73 — Malignant neoplasm of thyroid gland
- Additional: C77.0 — Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck (bilateral cervical disease)
- ICD-10-PCS: 0GTK0ZZ — Resection of Thyroid Gland, Open Approach
- ICD-10-PCS: 07T20ZZ — Resection of Right Neck Lymphatic, Open Approach
- ICD-10-PCS: 07T30ZZ — Resection of Left Neck Lymphatic, Open Approach
Sequencing: C73 is principal (thyroid cancer drove admission and is chiefly responsible for the surgical episode); C77.0 is additional for bilateral nodal disease. Since bilateral neck dissection was performed, both right and left PCS lymphatic resection codes are required per ICD-10-PCS multiple procedure coding rules.
CDI Note: Bilateral neck disease captured under a single C77.0 code is compliant; there is no bilateral modifier for this code. If disease extended to the mediastinal nodes in addition to cervical nodes, an additional C77.1 (intrathoracic lymph nodes) could be assigned — query the provider for documentation of mediastinal nodal involvement if PET-CT findings suggest it.
⚠️ Coding Pitfalls and Tips
-
Using C77.0 for primary lymphoma: The most critical compliance error is assigning C77.0 when the lymph node malignancy is actually a primary lymphoma (Hodgkin or non-Hodgkin). The Excludes 1 relationship with C81-C86 is an absolute rule — these code categories cannot be used together for the same lymph node. If documentation is unclear about whether the lymph node malignancy is primary or secondary, a CDI query is mandatory before any code is assigned. Misclassification of lymphoma as metastatic carcinoma (or vice versa) creates significant downstream errors in DRG grouping, HCC capture, cancer registry data, and treatment planning documentation.
-
Omitting the primary malignancy code: C77.0 is virtually never a standalone code — it always pairs with the primary malignancy code. Per ICD-10-CM Official Guideline I.C.2, both the primary site and all metastatic sites should be coded when documented. Assigning C77.0 without the corresponding primary (e.g., C32.0, C73, C10.x) is an incomplete coding scenario that understates clinical complexity, reduces HCC capture, and fails to fully represent the patient’s oncologic status for risk adjustment and quality reporting purposes.
-
Using C77.0 when cancer is in remission or resolved: C77.0 represents active metastatic nodal disease. If the patient had cervical lymph node metastasis that was treated and resolved (e.g., post-chemoradiation with complete response, no evidence of disease), the correct code is a personal history code (Z85.xx), not C77.0. Continuing to code C77.0 for resolved disease overstates active malignancy, creates false claims exposure, and inaccurately inflates risk scores. Always confirm with the provider whether the metastatic disease is active, in remission, or resolved before assigning C77.0.
-
Stacking C77.0 with C77.1, C77.2, etc. for multi-region disease: When nodal metastasis is documented across multiple lymph node regions (e.g., cervical AND mediastinal nodes), the correct code is C77.8 (lymph nodes of multiple regions) — not separate codes for each region. Assigning C77.0 + C77.1 simultaneously for bilateral multi-region disease is non-compliant; C77.8 is the single correct code for documented multi-region nodal involvement.
-
Missing the DRG impact of neck dissection PCS codes: In inpatient encounters where neck dissection is performed for nodal disease, the ICD-10-PCS resection/excision of cervical lymphatics is the O.R. procedure that can influence DRG grouping and relative weight. Failing to capture the neck dissection PCS code (or capturing it with incorrect Root Operation — Excision vs. Resection) is a common reimbursement error in ENT oncology encounters. Review every operative report for any lymph node dissection, biopsy, or sampling and code the corresponding PCS procedure.
-
Not querying for supraclavicular node laterality and level: While C77.0 does not have laterality or level subcharacters, the clinical documentation of cervical node level (I-V) and laterality (unilateral vs. bilateral) is critical for cancer registry staging accuracy, surgical planning documentation, and CDI quality. Coders should flag encounters where nodal levels are not documented and encourage provider specificity — even though the ICD-10-CM code itself does not differentiate, the downstream registry and staging implications are significant.